Insider Stock Trading History of Spiegelman Daniel K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Spiegelman Daniel K since year 2005. The trader's CIK number is 1238403. At the time of this reporting, Spiegelman Daniel K is the Director of Oncothyreon Inc. . (stock ticker symbol ONTY). See this page for all insider trading activities at Oncothyreon Inc. .

Note that in the past SPIEGELMAN DANIEL K also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Spiegelman Daniel K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-24 CASC Oncothyreon Inc. Option Ex 2,375 .00 0
2017-06-24 CASC Oncothyreon Inc. Option Ex 9,058 .00 0
2017-06-12 CASC Oncothyreon Inc. Option Ex 2,148 .00 0
2017-03-16 BMRN Biomarin Pharmaceutical Inc Sale 1,989 91.96 182,908
2017-03-06 BMRN Biomarin Pharmaceutical Inc Sale 2,303 93.32 214,915
2017-03-01 BMRN Biomarin Pharmaceutical Inc Sale 5,000 94.50 472,500
2017-02-28 BMRN Biomarin Pharmaceutical Inc Sale 30,000 94.00 2,820,000
2017-02-28 BMRN Biomarin Pharmaceutical Inc Option Ex 30,000 63.10 1,893,000
2017-01-09 BMRN Biomarin Pharmaceutical Inc Sale 5,000 90.00 450,000
2016-11-09 BMRN Biomarin Pharmaceutical Inc Sale 20,000 90.61 1,812,200
2016-08-01 BMRN Biomarin Pharmaceutical Inc Sale 4,000 99.33 397,320
2016-06-06 BMRN Biomarin Pharmaceutical Inc Sale 1,649 89.14 146,991
2016-06-07 RLYP Relypsa Inc Sale 1,013 19.31 19,562
2016-05-31 BMRN Biomarin Pharmaceutical Inc Option Ex 16,896 39.06 659,957
2016-05-31 BMRN Biomarin Pharmaceutical Inc Sale 20,841 89.67 1,868,916
2016-05-23 BMRN Biomarin Pharmaceutical Inc Sale 3,769 87.08 328,185
2016-03-02 BMRN Biomarin Pharmaceutical Inc Sale 4,623 86.12 398,118
2015-11-16 BMRN Biomarin Pharmaceutical Inc Option Ex 20,000 39.06 781,200
2015-11-16 BMRN Biomarin Pharmaceutical Inc Sale 20,000 104.30 2,085,920
2015-06-13 ONTY Oncothyreon Inc. Option Ex 16,042 .00 0
2015-06-05 BMRN Biomarin Pharmaceutical Inc Sale 1,649 122.30 201,669
2015-06-01 BMRN Biomarin Pharmaceutical Inc Sale 3,945 124.16 489,811
2015-05-29 BMRN Biomarin Pharmaceutical Inc Sale 1,578 126.15 199,064
2015-05-18 BMRN Biomarin Pharmaceutical Inc Sale 34,078 130.00 4,430,140
2015-05-18 BMRN Biomarin Pharmaceutical Inc Sale 2,059 124.77 256,905
2015-03-25 ONTY Oncothyreon Inc. Buy 10,000 1.63 16,270
2015-03-26 ONTY Oncothyreon Inc. Buy 10,000 1.59 15,860
2015-03-02 BMRN Biomarin Pharmaceutical Inc Option Ex 15,500 39.06 605,430
2015-03-02 BMRN Biomarin Pharmaceutical Inc Sale 15,500 107.00 1,658,500
2014-05-02 BMRN Biomarin Pharmaceutical Inc Sale 11 58.40 642
2014-09-03 BMRN Biomarin Pharmaceutical Inc Sale 18 69.77 1,255
2014-03-05 BMRN Biomarin Pharmaceutical Inc Sale 12 82.93 995
2013-07-10 ONTY Oncothyreon Inc. Sale 3,403 1.72 5,853
2013-02-20 ONTY Oncothyreon Inc. Sale 12,780 1.96 25,048
2014-09-02 BMRN Biomarin Pharmaceutical Inc Sale 16,000 69.83 1,117,312
2014-09-02 BMRN Biomarin Pharmaceutical Inc Option Ex 16,000 39.06 624,960
2014-08-01 BMRN Biomarin Pharmaceutical Inc Sale 2,229 61.76 137,651
2014-07-02 BMRN Biomarin Pharmaceutical Inc Sale 2,229 64.00 142,656
2014-03-11 ONTY Oncothyreon Inc. Option Ex 19,352 .00 0
2014-03-03 BMRN Biomarin Pharmaceutical Inc Option Ex 8,000 39.06 312,480
2014-03-03 BMRN Biomarin Pharmaceutical Inc Sale 8,000 80.32 642,528
2013-12-02 BMRN Biomarin Pharmaceutical Inc Option Ex 9,000 39.06 351,540
2013-12-02 BMRN Biomarin Pharmaceutical Inc Sale 9,000 70.14 631,269
2013-09-04 BMRN Biomarin Pharmaceutical Inc Option Ex 9,000 39.06 351,540
2013-09-04 BMRN Biomarin Pharmaceutical Inc Sale 9,000 69.00 621,000
2013-07-01 BMRN Biomarin Pharmaceutical Inc Sale 4,066 59.78 243,061
2013-05-01 BMRN Biomarin Pharmaceutical Inc Sale 28,000 64.42 1,803,900
2013-05-01 BMRN Biomarin Pharmaceutical Inc Option Ex 28,000 39.06 1,093,680
2011-06-12 ONTY Oncothyreon Inc. Option Ex 2,076 .00 0
2009-04-02 CVTX Cv Therapeutics Inc Option Ex 188,958 12.31 2,326,639
2009-04-02 CVTX Cv Therapeutics Inc Sale 141,029 19.91 2,807,887
2009-02-25 CVTX Cv Therapeutics Inc Option Ex 12,499 15.58 194,734
2008-12-11 CVTX Cv Therapeutics Inc Option Ex 5,000 8.48 42,400
2008-12-09 CVTX Cv Therapeutics Inc Option Ex 5,000 9.51 47,550
2008-02-26 CVTX Cv Therapeutics Inc Option Ex 4,688 6.95 32,581
2007-12-21 CVTX Cv Therapeutics Inc Sale 6,000 10.00 60,000
2007-12-10 CVTX Cv Therapeutics Inc Sale 8,000 10.03 80,240
2007-01-17 CVTX Cv Therapeutics Inc Sale 7,000 13.93 97,510
2007-01-03 CVTX Cv Therapeutics Inc Option Ex 12,732 .00 0
2006-12-12 CVTX Cv Therapeutics Inc Sale 3,000 12.92 38,760
2006-12-05 CVTX Cv Therapeutics Inc Option Ex 5,000 .00 0
2006-01-03 CVTX Cv Therapeutics Inc Option Ex 121 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Spiegelman Daniel K (Director of Oncothyreon Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.